Skip to content
Sign in
Artwork for ASCO Education
ASCO Education · July 13 · 19 min

Optimizing Frontline ADCs: Sequencing, Targets, and Resistance

Dr. Pedro Barata and Dr. Giuseppe Curigliano discuss the rapid paradigm shift of antibody-drug conjugates into frontline advanced and curative-intent perioperative settings and the clinical challenges of optimal sequencing, target selection, and cross-resistance. LINK TO FULL TRANSCRIPT

0:00-19:01
Play in

transcript

No transcript — this publisher did not publish one.

show notes

Dr. Pedro Barata and Dr. Giuseppe Curigliano discuss the rapid paradigm shift of antibody-drug conjugates into frontline advanced and curative-intent perioperative settings and the clinical challenges of optimal sequencing, target selection, and cross-resistance.

LINK TO FULL TRANSCRIPT

links2

more episodes

All episodes